Dramatic response after functional hemispherectomy in a patient with epileptic encephalopathy carrying a de novo COL4A1 mutation

被引:8
|
作者
Hino-Fukuyo, Naomi [1 ,2 ]
Kikuchi, Atsuo [2 ]
Iwasaki, Masaki [3 ]
Sato, Yuko [2 ]
Kubota, Yuki [2 ]
Kobayashi, Tomoko [2 ]
Nakayama, Tojo [2 ]
Haginoya, Kazuhiro [2 ,4 ]
Arai-Ichinoi, Natsuko [2 ]
Niihori, Tetsuya [1 ,5 ]
Sato, Ryo [2 ]
Suzuki, Tasuku [2 ]
Kudo, Hiroki [2 ]
Funayama, Ryo [6 ]
Nakayama, Keiko [6 ]
Aoki, Yoko [1 ,5 ]
Kure, Shigeo [2 ]
机构
[1] Tohoku Univ Hosp, Ctr Genom Med, Sendai, Miyagi, Japan
[2] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi, Japan
[3] Natl Ctr Hosp Neurol & Psychiat, Dept Neurosurg, Kodaira, Tokyo, Japan
[4] Miyagi Childrens Hosp, Dept Neurol, Sendai, Miyagi, Japan
[5] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan
[6] Tohoku Univ, Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Miyagi, Japan
来源
BRAIN & DEVELOPMENT | 2017年 / 39卷 / 04期
基金
日本学术振兴会;
关键词
COL4A1; Epileptic encephalopathy; Hemiplegia; Porencephaly; Infantile spasms; Functional hemispherectomy; COL4A1; MUTATIONS; HEMORRHAGE;
D O I
10.1016/j.braindev.2016.11.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe the first case of a successful functional hemispherectomy in a patient with epileptic encephalopathy and a de novo collagen type IV alpha 1 (COL4A1) mutation. A 4-year-old girl was COL4A1 mutation-positive and suffered from drug-resistant epilepsy, hemiplegia, and developmental delay. Magnetic resonance imaging detected no porencephaly, and she had no cataract or renal abnormality. Following a presurgical evaluation for epilepsy, she underwent a functional hemispherectomy. She has been seizure free with no intracranial hemorrhage or other perioperative complications. Patients with a COL4A1 mutation have an increased risk for intracranial hemorrhage because of disrupted integrity in the vascular basement membrane due to the mutation. After weighing the risks and benefits to these patients, epilepsy surgery may not be absolutely contraindicated. Furthermore, pediatric neurologists should be aware of an undiagnosed COL4A1 mutation when a patient presents with an unexplained neurological phenotype, such as mild hemiparesis, even in the absence of porencephaly. (C) 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [31] Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation
    Watanabe, Jun
    Okamoto, Kouichirou
    Ohashi, Tsukasa
    Natsumeda, Manabu
    Hasegawa, Hitoshi
    Oishi, Makoto
    Miyatake, Satoko
    Matsumoto, Naomichi
    Fujii, Yukihiko
    WORLD NEUROSURGERY, 2019, 127 : 446 - 450
  • [32] Dramatic response to pyridoxine in a girl with absence epilepsy with ataxia caused by a de novo CACNA1A mutation
    Du, Xiaoping
    Chen, You
    Zhao, Yongxiong
    Luo, Wei
    Cen, Zhidong
    Hao, Weicheng
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 45 : 189 - 191
  • [33] De novo p.G696S mutation in COL4A1 causes intracranial calcification and late-onset cerebral hemorrhage: A case report and review of the literature
    Kinoshita, Keishiro
    Ishizaki, Yoshito
    Yamamoto, Hiroyuki
    Sonoda, Motoshi
    Yonemoto, Kousuke
    Kira, Ryutaro
    Sanefuji, Masafumi
    Ueda, Akihiko
    Matsui, Hirotaka
    Ando, Yukio
    Sakai, Yasunari
    Ohga, Shouichi
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2020, 63 (04)
  • [34] A De Novo Dominant Negative Mutation in DNM1L Causes Sudden Onset Status Epilepticus with Subsequent Epileptic Encephalopathy
    Schmid, S. J.
    Wagner, M.
    Goetz, C.
    Makowski, C.
    Freisinger, P.
    Berweck, S.
    Mall, V.
    Burdach, S.
    Juenger, H.
    NEUROPEDIATRICS, 2019, 50 (03) : 197 - 201
  • [35] A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy
    Fahrner, Jill A.
    Liu, Raymond
    Perry, Michael Scott
    Klein, Jessica
    Chan, David C.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2016, 170 (08) : 2002 - 2011
  • [36] Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib
    Yang, Jing-Xiao
    Jia, Zi-Yao
    Liu, Fa-Tao
    Wu, Wen-Guang
    Li, Xue-Chuan
    Zou, Lu
    Li, Huai-Feng
    Zhang, Fei
    Bao, Run-Fa
    Peng, Shu-You
    Lau, Wan Yee
    Liu, Yun
    Li, Mao-Lan
    Liu, Ying-Bin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Dramatic response to brigatinib in a lung adenocarcinoma patient harboring EML4-ALK fusion and a G1202R de novo gene mutation
    Pan, Yue
    Zeng, Yue
    Peng, Yurong
    Liu, Xiaohan
    Li, Yizheng
    Wu, Fang
    EUROPEAN JOURNAL OF CANCER, 2022, 165 : 154 - 156
  • [38] De Novo COL7A1 mutation in a patient with trisomy 21: coexistence of dystrophic epidermolysis bullosa and Down syndrome
    Catalan, Javiera A.
    Rodriguez, Fernando A.
    Yubero, Maria J.
    Palisson, Francis
    Gana, Maria J.
    Kraemer, Susanne M.
    Repetto, Gabriela M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (09) : 1078 - 1081
  • [39] Perampanel treatment in early-onset epileptic encephalopathy with infantile movement disorders associated with de novo GRIN1 gene mutation
    Pironti, E.
    Cucinotta, F.
    Galati, C.
    Di Rosa, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1110 - S1111
  • [40] Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results
    Gerald, Brittany
    Ramsey, Keri
    Belnap, Newell
    Szelinger, Szabolcs
    Siniard, Ashley L.
    Balak, Chris
    Russell, Megan
    Richholt, Ryan
    De Both, Matt
    Claasen, Ana M.
    Schrauwen, Isabelle
    Huentelman, Matthew J.
    Craig, David W.
    Rangasamy, Sampathkumar
    Narayanan, Vinodh
    SEMINARS IN PEDIATRIC NEUROLOGY, 2018, 26 : 28 - 32